← Back to Clinical Trials
Recruiting NCT06557707

NCT06557707 Cardiovascular Health & Early Stress

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06557707
Status Recruiting
Phase
Sponsor Virginia Commonwealth University
Condition Stress
Study Type OBSERVATIONAL
Enrollment 120 participants
Start Date 2022-01-20
Primary Completion 2027-12

Eligibility & Interventions

Sex All sexes
Min Age 9 Years
Max Age 30 Years
Study Type OBSERVATIONAL
Interventions
Childhood stress

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 120 participants in total. It began in 2022-01-20 with a primary completion date of 2027-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Childhood adversity is highly prevalent, with 59% of the U.S. population reporting at least one adverse childhood experience (ACE). Substantial evidence links childhood adversity to cardiometabolic disease later in the life course, including heart disease, diabetes, and stroke, which are 3 of the top 10 causes of mortality in the United States. ACEs encompass many possible traumatic and distressing experiences, including abuse, neglect, or severe household dysfunctions. It is not surprising that the experience of those extreme events during the first decade of life has tremendous implications for the individual's psychological and physical health.

Eligibility Criteria

Inclusion Criteria: Cohort 1 * Men and pre-menopausal women * 18-30 years old Cohort 2 * males and females * 9-17 years old Exclusion Criteria: Cohort 1 * Evidence of cardiovascular, pulmonary, renal, hepatic or cerebral diseases * Evidence of pregnancy or currently nursing. * Having a history of chronic pain * Having a history of rheumatoid arthritis Cohort 2 * Evidence of cardiovascular, pulmonary, renal, hepatic or cerebral diseases * Evidence of pregnancy or currently nursing. * Having a history of chronic pain * Having a history of rheumatoid arthritis

Contact & Investigator

Central Contact

Paula Rodriguez Miguelez

✉ prodriguezmig@vcu.edu

📞 (804) 396-4498

Principal Investigator

Paula Rodriguez Miguelez

PRINCIPAL INVESTIGATOR

Virginia Commonwealth University

Frequently Asked Questions

Who can join the NCT06557707 clinical trial?

This trial is open to participants of all sexes, aged 9 Years or older, up to 30 Years, studying Stress. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06557707 currently recruiting?

Yes, NCT06557707 is actively recruiting participants. Contact the research team at prodriguezmig@vcu.edu for enrollment information.

Where is the NCT06557707 trial being conducted?

This trial is being conducted at Richmond, United States.

Who is sponsoring the NCT06557707 clinical trial?

NCT06557707 is sponsored by Virginia Commonwealth University. The principal investigator is Paula Rodriguez Miguelez at Virginia Commonwealth University. The trial plans to enroll 120 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology